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Abstract
This study examined whether activities of daily living (ADL) mediate the relationship between depression and health-related
quality of life (HR-QOL) in people with Parkinson’s disease (PD). A cross-sectional, correlational research design examined
data from 174 participants who completed the Geriatric Depression Scale (GDS-15), Parkinson’s Disease Questionnaire-39
(PDQ-39), and Unified Parkinson’s Disease Rating Scale-section 2 (UPDRS-section 2 [ADL]). Multiple Regression Analysis
(MRA) was used to examine the mediator model. Depression and ADL significantly (p,.001) predicted HR-QOL, and
depression significantly (p,.001) predicted ADL. Whilst ADL did not impact on the relationship between depression and HR-
QOL, there was a significant (p,.001) indirect effect of depression on HR-QOL via ADL, suggesting both direct and indirect
(via ADL) effects of depression on HR-QOL. The magnitude of this effect was moderate (R2 = .13). People with PD who report
depression also experience greater difficulty completing ADL, which impacts upon their HR-QOL. It is recommended that
clinicians adopt a multidisciplinary approach to care by combining pharmacological treatments with psycho/occupational
therapy, thereby alleviating the heterogeneous impact of motor and non-motor symptoms on HR-QOL in people with PD.
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Introduction
In addition to the cardinal motor symptoms of Parkinson’s
disease (PD), approximately 42% of people with PD report
depressive symptoms [1]. Research suggests that comorbid
depression in PD adversely impacts both health-related quality
of life (HR-QOL) and the capacity to complete activities of daily
living (ADL) [2].
Poor motor function, body discomfort and pain are common
consequences of PD, which can lead to social isolation and
negatively impact HR-QOL [3]. Depression is also a strong
predictor of poor HR-QOL in PD [4]. Schrag et al. [5] examined
the impact of depression on HR-QOL in PD and found those with
high levels of depression demonstrated significantly lower HR-
QOL, compared to participants without depression. Likewise,
Quelhas and Costa [4] and Carod-Artal et al. [6] also found that
depressed participants had poorer HR-QOL compared to non-
depressed participants. Indeed, depression may be a more
significant predictor of HR-QOL in PD than motor symptoms [5].
In an examination of the relationship between motor (e.g.,
tremor) and non-motor (e.g., depression) symptoms and HR-QOL
in PD, Qin et al. [7] found that non-motor symptoms accounted
for 62% of the variance in HR-QOL scores, compared to motor
symptoms which accounted for just 19%. A recent systematic
review by Soh et al. [8] of the most significant contributors to HR-
QOL in PD confirmed the importance of depression. Nineteen of
the 29 studies included examined the impact of depression on HR-
QOL, and all found that depression was the greatest significant
predictor of HR-QOL.
Activities of Daily Living (ADL) are difficult for people with PD
[9]. There is, however, limited research into the relationship
between ADL and depression in PD [2]. Papapetropoulos et al.
[10] examined whether there were any significant differences
between the ADL of depressed and non-depressed people with
PD. Participants who were depressed scored significantly worse on
measures of ADL than those not depressed [10]. Piccinni et al.
[11] examined the relationship between depression in people with
PD and their degree of functional disability. They found that
participants with high levels of depression (severe or moderate)
scored significantly worse on ADL measures than participants with
low levels of depression (mild). Finally, Dissanayaka et al. [2]
reported a stronger negative relationship between impaired ADL
and depression than the severity of motor symptoms in PD. These
results suggest that as the severity of depressive symptoms
increases, people with PD experience greater difficulty completing
ADL regardless of the severity of their motor symptoms.
In addition to the relationship between ADL and depression,
research has identified a significant relationship between ADL and
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HR-QOL [8,12]. In Soh et al.’s [8] systematic review, impairment
in daily functioning was identified in eight studies as a significant
predictor of HR-QOL in PD. Rahman et al. [13] examined the
impact of PD symptoms on the HR-QOL of people with PD. ADL
significantly predicted HR-QOL and depression accounted for a
significant 40.8% of the variance in HR-QOL [13]. These results
indicate that ADL and depression independently predict poorer
HR-QOL [13]. Kleiner-Fisman et al. [14] examined the
correlation between specific PD symptoms and predictors of
HR-QOL. As with depression, the strongest relationship was
between ADL and HR-QOL, suggesting that the loss of
independence and inability to complete ADL may also be more
important determinants of HR-QOL than the motor symptoms of
PD [14]. Taken together, these studies provide convincing
evidence that depressive symptoms and the inability to complete
ADL independently significantly impact upon HR-QOL in those
with PD, beyond the impact of the severity of their motor
symptoms.
Despite strong evidence that both depression and ADL are
important determinants of HR-QOL in PD, and that depression
leads to poorer ADL, no study to date has examined the impact of
ADL and depression on HR-QOL. One possibility is that
depression reduces ADL, which leads to poorer HR-QOL. That
is, that the effect of depression on HR-QOL is mediated by ADL.
Another is that both depression and ADL independently predict
HR-QOL, and a final possibility is that depression has both direct
and indirect effects on HR-QOL, in part via ADL.
The present study examined the relationship between depres-
sion and HR-QOL in people with PD. The following hypotheses
were tested: (1) depression significantly predicts HR-QOL, (2)
depression significantly predicts ADL, (3) ADL significantly
predicts HR-QOL, and (4) ADL significantly mediates the
relationship between depression and HR-QOL.
Methods
1. Participants
People with idiopathic PD in Western Australia were invited to
participate in the Parkinson’s Centre (ParkC) research project
located at Edith Cowan University. Participants were recruited
through advertising, and referrals from neurologists and physi-
cians. To be included in the study, participants must have been
formally diagnosed with PD in accordance with the United
Kingdom Parkinson’s Disease Society Brain Bank Clinical Criteria
(UKPDSBBC). Participants were excluded from the study if they
scored below 24 on the Mini Mental Status examination (MMSE)
[15]. The final sample included 174 participants (119 male),
ranging in age from 41 to 85 years (M = 65.96, SD = 9.46). All
participants provided written informed consent. Edith Cowan
University’s Research Ethics Committee approved this study.
2. Measures
The Geriatric Depression Scale-15 (GDS-15) is a self-report
measure used to detect depression in older adults and contains 15
questions that require participants to answer ‘‘no’’ or ‘‘yes’’ and
are summed to a total of 15 [16]. The GDS-15 is suitable for use in
PD as it focuses on the social/psychological factors of depression
and excludes the shared somatic symptoms of PD, thereby
addressing problems of symptom overlap found with other
measures [17]. The internal consistency (Cronbach’s alpha) of
the GDS-15 in the present study was a= .79.
The Parkinson’s Disease Questionnaire-39 (PDQ-39) contains
39 items across eight dimensions of HR-QOL (mobility, activities
of daily living [ADL], emotional well-being, stigma, social support,
cognitions, communication, and bodily discomfort) [18]. Items are
scored from ‘‘0 = never’’ to ‘‘4 = always (or cannot do at all)’’ and
within each dimension the items are computed into a total score,
by dividing the sum of question scores by the maximum score for
that dimension and multiplying by 100 [18]. Each dimension
ranges from ‘‘0 = no problem’’ to ‘‘100 = maximum level of
problem’’ [18]. Higher scores indicate poorer HR-QOL. The
PDQ-39 has been identified as a ‘recommended’ measure for use
in PD for both clinical trials and epidemiological studies [19]. This
study used a single index (SI) score by summing the dimension
scores and dividing by eight. The SI score also ranges from
‘‘0 = no problem’’ to ‘‘100 = maximum level of problem’’ [18].
The internal consistency of the PDQ-39 in the present study was
a= .93.
The UPDRS-section II (ADL) is the second subscale of the
UPDRS, which assesses ADL among people with PD [20]. The
UPDRS-section II (ADL) is completed by the researcher during an
assessment and contains 13 items, each scored either ‘‘0 = nor-
mal’’, ‘‘1 = slight’’, ‘‘2 = mild’’, ‘‘3 = moderate’’ or ‘‘4 = severe’’
difficulty with the task. Higher scores indicate greater severity of
motor symptoms and greater interference with the participants’
ability to complete ADL independently [21]. For the purposes of
this study, a total score was calculated by summing the scores from
the 13 items and dividing by 13. Internal consistency of the 13
items used in the present study was a= .84.
3. Procedure
Assessment times were scheduled during the participant’s ‘on’
stage, approximately one hour post-medication. Each assessment
was conducted by a trained researcher and took approximately
2.5 hours.
Results
Independent samples t-tests revealed no significant gender
differences for depression, ADL, and HR-QOL (p..05). Bivariate
correlations determined whether age significantly correlated with
depression, ADL, and HR-QOL. Older age was associated with
poorer ADL and was retained as a covariate (see Table 1).
As predicted (Hypothesis 1), depression significantly correlated
with HR-QOL and ADL. After controlling for the influence of
age, depression remained a significant predictor of HR-QOL,
accounting for an additional 23.3% of variance. Likewise,
consistent with prediction (Hypothesis 3), ADL also significantly
correlated with HR-QOL. Again, after controlling for age, ADL
accounted for an additional and significant 19.2% of the variance
in HR-QOL. The overall model of age, depression, and ADL was
significant, R2 = .59, adjusted R2 = .59, F (3, 170) = 82.54, p,.001.
Finally, and as predicted (Hypothesis 2) depression was a
significant predictor of ADL after controlling for age, accounting
for an additional 7.7% of the variance in ADL, F (1, 171) = 14.62,
p,.001. Age and depression combined accounted for a significant
10.5% of the variance in ADL, R2 = .11, adjusted R2 = .10, F (2,
171) = 10.05, p,.001.
A Sobel test was used to test whether ADL had a significant
indirect effect on the relationship between depression and HR-
QOL [22]. The Sobel test result was significant, z = 3.58 (p,.001),
indicating that ADL does have a significant, indirect effect on the
relationship between depression and HR-QOL. Given the above
relationships, hierarchical multiple regression analysis (MRA) was
used to determine whether ADL mediates the relationship
between depression and HR-QOL.
A final MRA tested whether this mediation effect was complete
or partial. At Step 2, age and depression accounted for 40.1% of
Activities of Daily Living in Parkinson’s Disease
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the variance in HR-QOL, R2 = .40, adjusted R2 = .39, F (2,
171) = 57.22, p,.001. ADL was entered at Step 3 and accounted
for an additional 19.2% of the variance in HR-QOL, DR2 = .19, F
(1, 170) = 80.18, p,.001. Depression accounted for a significant
39.9% of the variance of HR-QOL at Step 2. However, when
ADL was entered at Step 3, the amount of unique variance
accounted for by depression reduced to 23.3% although this
remained significant. Therefore, partial mediation can be inferred.
Table 2 provides the MRA results.
To declare partial mediation the change in the effect of
depression on HR-QOL from Steps 2 to 3 must be a significant
change [23]. A z test was conducted using the unstandardized beta
coefficients and corresponding standard error values to determine
the significance of the indirect effect of ADL [23]. A value greater
than 1.96 at a= .05 is necessary for partial mediation [23]. The z
test value of 1.65 indicates no significant difference between the
two path coefficients. The change in depression when ADL was
entered into the model was not a significant change, indicating that
ADL does not partially mediate the relationship between
depression and HR-QOL, thus hypothesis (4) was rejected.
However, the Sobel test indicates that there remained a significant
indirect effect of ADL on the relationship between depression and
HR-QOL. Based on Cohen’s [24] conventions the magnitude of
this effect was moderate, R2 = .13.
The previous analyses were repeated to examine whether
shared variance between the UPDRS-section II (ADL) and the
PDQ-39 (ADL-subscale) had any effect on the results. With the
PDQ-39 (ADL-subscale) removed from the model, a significant
Sobel test z = 3.40 (p,.001) indicated that ADL had a significant
indirect effect on the depression and HR-QOL relationship [22].
MRA tested for complete or partial mediation. At Step 2, age and
depression account for 42.6% (increase of 1.5%) of the variance in
HR-QOL, R2 = .43, adjusted R2 = .42, F (2, 171) = 63.40, p,.001.
ADL was entered at Step 3 and accounted for an additional 14.2%
(decrease of 5%) of the variance in HR-QOL, DR2 = .14, F (1,
170) = 55.65, p,.001. Depression accounted for a significant
42.5% (increase of 1.6%) of the variance in HR-QOL at Step 2.
However, when ADL was entered at Step 3, the amount of unique
Table 1. Descriptive statistics and correlations between study variables.
Variable Mean SD 1 2 3
1. Age 65.96 9.46 -
2. Depression (max 15) 3.20 2.86 .05 -
3. Activities of Daily Living (max 4) .85 .53 .17* .29** -




SD = Standard deviation.
doi:10.1371/journal.pone.0102294.t001
Table 2. Hierarchical Regression Model Analyses for the Indirect Effect of Activities of Daily Living on Depression and Health-
Related Quality of Life.
Predictor R2 b B Part Correlation
Step 1a .03
Age .17* .01 .17
Step 2a .11**
Age .16* .01 .16
Depression .28** .05 .28
Step 1b .00
Age .05 .06 .05
Step 2b .40**
Age .02 .02 .02
Depression .63** 2.75 .63
Step 3b .59**
Age .2.06 2.075 2.06
Depression .50** 2.19 .48




R2 = R Square; b= Standardised beta coefficient; B = Unstandardised B coefficient; Part Correlation = Unique variance of each predictor;
a = Dependent variable is activities of daily living;
b = Dependent variable is health-related quality of life.
doi:10.1371/journal.pone.0102294.t002
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variance accounted for by depression reduced to 27% (increase of
3.7%) although this remained significant. This result infers partial
mediation.
With the PDQ-39 (ADL-subscale) is removed from the model, a
z test returned a value of 1.40 to indicate that ADL does not
partially mediate the relationship between depression and HR-
QOL [23]. Nonetheless, the significant Sobel test indicates that
ADL has a significant indirect effect on the relationship between
depression and HR-QOL. The magnitude of this effect remained
moderate, R2 = .11 (decrease of .2) [24].
Discussion
This is the first study to examine whether ADL mediates the
relationship between depression and HR-QOL in people with PD.
ADL demonstrated a signficant indirect effect on the depression
and HR-QOL relationship, but did not reduce the relationship
such that a partial mediation effect could be declared [23].
Although this result did not support hypothesis (4), the size of the
indirect effect was moderate and suggests that people with PD with
depressive symptoms also experience greater difficulty completing
ADL, which consequently impacts upon their HR-QOL.
There are several implications from the present finding. Firstly,
it may be valuable for clinicians to consider the non-motor factors
relating to HR-QOL in people with PD [13]. Assessment of
depressive symptoms and ADL in people with PD would provide a
clearer understanding of these non-motor relationships and
promote a multidisciplinary approach to care [8,13]. A multidis-
ciplinary approach combining pharmacological management with
psycho/occupational therapy could alleviate the heterogeneous
impact of motor and non-motor symptoms on HR-QOL in people
with PD [13,25,26].
Secondly, the present findings highlight the complex interaction
between non-motor symptoms and daily functioning in PD.
Previous research has demonstrated that people with PD with
more knowledge of the disease course are less likely to be
depressed [2]. Educating people with PD about the impact of
depression and impaired ADL may help them to better manage
their symptoms, potentially reducing the likelihood of depression,
and improving their HR-QOL [27].
Finally, the present findings suggest that depression and
impaired ADL in combination lead to worse HR-QOL than the
impact of the two independently. Therefore, psychotherapy
interventions (e.g., CBT) for people with PD and depression
may have additional benefits for those who also experience
difficulty with ADL. Cognitive-behavioural therapy (CBT) can
promote acceptance of assistance by a caregiver to provide help
with ADL and combat feelings of dependence and helplessness for
people with PD [27]. The CBT framework can include caregivers
and family members as part of the treatment for the person with
PD [27]. CBT teaches caregivers and family members techniques
for supporting the person with PD, enabling them to respond
positively when feelings of helplessness, dependence and depres-
sion are experienced by the person with PD [27].
In addition to the significant indirect effect, depression was the
strongest predictor of HR-QOL (Hypothesis 1). This result is
consistent with findings by Schrag et al. [3] and Qin et al. [7].
Previous studies have also reported that people with PD and
depression score significantly worse on measures of HR-QOL than
people with PD without depression [6]. The present findings
confirm that depression is a significant determinant of HR-QOL
for Western Australian people with PD.
Supporting previous research by Dissanayaka et al. [2],
depression significantly predicted ADL, whereby participants with
depression reported greater impairment in ADL (Hypothesis 2).
The significant relationship between depression and ADL was
previously reported Piccinni et al. [11], who found that
impairment in ADL increased as the severity of depression
increased.
ADL accounted for a significant proportion of variance in HR-
QOL (Hypothesis 3). Kleiner-Fisman et al. [14] reported a similar
significant relationship between ADL and HR-QOL for people
with PD, whereby impaired ADL was associated with poorer HR-
QOL. As motor symptoms progress, people with PD experience
difficulty completing simple tasks such as using eating utensils,
dressing, and walking [10]. These diffiulties adversely impact their
HR-QOL [8]. The present study used a total index score for ADL;
which can limit the ability to distinguish between the impact of
specific ADL on HR-QOL. However, the present findings suggest
that participants who reported difficulty completing ADL also
reported a poorer HR-QOL.
The present results should be considered within some limita-
tions. The participants’ mean score for depressive symptoms was
below the diagnostic cut off for depression, and the mean scores
for ADL and HR-QOL were within the ‘normal’ to ‘slightly
impaired’ range [17,18,21]. This limited degree of impairment
and symptom severity reduces the generalisability of the findings to
the PD population [28]. Depression and impaired HR-QOL have
been found in early stages of PD [28]. In addition, the prevalence
of comorbid minor and major depression has been reported at
22% and 17% [29]. This relatively unimpaired sample reflects the
early stage of PD onset of these participants, which may have
contributed to the lack of partial mediation. Lastly, due to the
cross-sectional design of this study, it is difficult to determine the
temporal relationship between depression, ADL, and HR-QOL.
The novel nature of the indirect effect of ADL on the depression
and HR-QOL relationship in PD provides opportunities for future
research. Recruitment of a sample that captures the spectrum of
symptom severity would provide a more accurate representation of
the heterogeneity in PD and increase both the external validity of
the results and the possibility of finding mediation effects [30].
Furthermore, a longitudinal investigation gathering depression
scores at Time 1, ADL scores at Time 2, and HR-QOL scores at
Time 3, would allow causal inferences to be made when
interpreting a mediation effect.
In conclusion, this is the first study to demonstrate a significant
indirect effect of ADL on the depression and HR-QOL
relationship in PD. The moderate effect size suggests that people
with PD and depressive symptoms experience greater difficulty
completing ADL, which adversely impacts upon their HR-QOL.
It is recommended that clinicians adopt a multidisciplinary
approach when caring for people with PD and consider the
relationships between depression, ADL, and HR-QOL. Undoubt-
edly, this significant effect warrants further investigation and
accentuates the relationship between depression and HR-QOL in
PD.
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